Cartesian Therapeutics Statistics
Total Valuation
RNAC has a market cap or net worth of $298.08 million. The enterprise value is $205.12 million.
| Market Cap | 298.08M |
| Enterprise Value | 205.12M |
Important Dates
The next estimated earnings date is Thursday, August 15, 2024, before market open.
| Earnings Date | Aug 15, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
RNAC has 17.80 million shares outstanding. The number of shares has increased by 5.92% in one year.
| Shares Outstanding | 17.80M |
| Shares Change (YoY) | +5.92% |
| Shares Change (QoQ) | +2.26% |
| Owned by Insiders (%) | 60.73% |
| Owned by Institutions (%) | 11.13% |
| Float | 3.59M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 11.51 |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 7.92 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.03
| Current Ratio | 3.03 |
| Quick Ratio | 2.94 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -134.24 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -116.40% |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | $700,162 |
| Profits Per Employee | -$6.89M |
| Employee Count | 37 |
| Asset Turnover | 0.12 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -19.00M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -53.07% in the last 52 weeks. The beta is 0.83, so RNAC's price volatility has been lower than the market average.
| Beta (5Y) | 0.83 |
| 52-Week Price Change | -53.07% |
| 50-Day Moving Average | 25.91 |
| 200-Day Moving Average | 25.39 |
| Relative Strength Index (RSI) | 31.28 |
| Average Volume (20 Days) | 185,747 |
Short Selling Information
The latest short interest is 811,442, so 4.56% of the outstanding shares have been sold short.
| Short Interest | 811,442 |
| Short Previous Month | 903,327 |
| Short % of Shares Out | 4.56% |
| Short % of Float | 22.63% |
| Short Ratio (days to cover) | 8.60 |
Income Statement
In the last 12 months, RNAC had revenue of $25.91 million and -$254.87 million in losses. Loss per share was -$56.10.
| Revenue | 25.91M |
| Gross Profit | 25.91M |
| Operating Income | -81.38M |
| Pretax Income | -273.87M |
| Net Income | -254.87M |
| EBITDA | -269.18M |
| EBIT | -271.85M |
| Loss Per Share | -$56.10 |
Balance Sheet
The company has $103.42 million in cash and $10.46 million in debt, giving a net cash position of $92.96 million or $5.22 per share.
| Cash & Cash Equivalents | 103.42M |
| Total Debt | 10.46M |
| Net Cash | 92.96M |
| Net Cash Per Share | $5.22 |
| Equity (Book Value) | -116.80M |
| Book Value Per Share | -6.56 |
| Working Capital | 74.46M |
Cash Flow
In the last 12 months, operating cash flow was -$58.31 million and capital expenditures -$678,000, giving a free cash flow of -$58.99 million.
| Operating Cash Flow | -58.31M |
| Capital Expenditures | -678,000 |
| Free Cash Flow | -58.99M |
| FCF Per Share | -$10.90 |
Margins
Gross margin is 100.00%, with operating and profit margins of -314.15% and -983.83%.
| Gross Margin | 100.00% |
| Operating Margin | -314.15% |
| Pretax Margin | -1,057.17% |
| Profit Margin | -983.83% |
| EBITDA Margin | -1,039.05% |
| EBIT Margin | -1,049.36% |
| FCF Margin | -227.71% |
Dividends & Yields
RNAC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -5.92% |
| Shareholder Yield | -5.92% |
| Earnings Yield | -85.50% |
| FCF Yield | -19.79% |
Analyst Forecast
The average price target for RNAC is $43.75, which is 177.43% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $43.75 |
| Price Target Difference | 177.43% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | 10.66% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on April 5, 2024. It was a reverse split with a ratio of 1:30.
| Last Split Date | Apr 5, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:30 |
Scores
RNAC has an Altman Z-Score of -4.89 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -4.89 |
| Piotroski F-Score | 2 |